RLAY — Relay Therapeutics
Median target
$26
calls from the last 12 months
Implied return
+35.5%
median target vs. price
Coverage
15 analysts · 21 calls
updated in the last 12 months
Consensus
14/1/0+14 net
Buy / Hold / Sell
Which analysts are behind RLAY's consensus?
See every current rating, price target and the analysts' track records for Relay Therapeutics — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 15 analysts with calls on RLAY updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
RLAY elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-08 | Insiders | Patel SanjivPresident and CEO | Insider sale | 48.2K sh @ $18.94 · planned trade | $913K |
| 2026-09-08 | Insiders | Catinazzo ThomasChief Financial Officer | Insider sale | 17.7K sh @ $18.94 · planned trade | $336K |
| 2026-09-08 | Insiders | Bergstrom Donald APresident, R&D | Insider sale | 8.5K sh @ $18.97 · planned trade | $162K |
| 2026-08-26 | Insiders | Rahmer PeterSee remarks | Insider sale | 4.5K sh @ $20.03 · planned trade | $90K |
| 2026-08-25 | Insiders | Svf Pauling (Cayman) Ltd +210% owner | Insider sale | 6.0M sh @ $19.40 | $116.4M |
| 2026-08-25 | Insiders | Svf Pauling (Cayman) Ltd | Proposed sale | 6.0M units · 2.74% of shares outstanding | $123.4M |
| 2026-08-17 | Insiders | Patel SanjivPresident and CEO | Insider sale | 48.2K sh @ $20.33 · planned trade | $980K |
| 2026-08-14 | Insiders | Catinazzo ThomasChief Financial Officer | Insider sale | 17.7K sh @ $19.74 · planned trade | $350K |
| 2026-07-28 | Insiders | Bergstrom Donald APresident, R&D | Insider sale | 2.2K sh @ $18.61 | $42K |
| 2026-07-28 | Insiders | Catinazzo ThomasChief Financial Officer | Insider sale | 1.5K sh @ $18.61 | $27K |
More: congressional trades on RLAY · insider activity · executive branch · trending